Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chitra Venugopal

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
Oncogene|November 8, 2019
A CD133-AKT-Wnt signaling axis drives glioblastoma brain tumor-initiating cellsBranavan Manoranjan, Chirayu Chokshi, Chitra Venugopal, et al.
Scientific Reports|October 16, 2025
CRISPR screen reveals SOX2 as a critical regulator of CD133 and cellular stress response in glioblastomaNeil Savage, Etienne Danis, Chirayu R Chokshi, et al.
Iscience|April 9, 2025
DAP12-associated synthetic antigen receptors enable multi-targeting of T cells with independent chimeric receptors in a small genetic payloadAllyson E Moore, Hayley Nault, Derek Cummings, et al.
Frontiers in Immunology|July 25, 2022
Dual Antigen T Cell Engagers Targeting CA9 as an Effective Immunotherapeutic Modality for Targeting CA9 in Solid TumorsNazanin Tatari, Xiaoyu Zhang, Shawn C Chafe, et al.
Journal of Alzheimer'S Disease : JAD|April 14, 2009
Challenges associated with metal chelation therapy in Alzheimer's diseaseMuralidhar L Hegde, P Bharathi, Anitha Suram, et al.
Neuro-Oncology|January 11, 2025
Disease stage-specific role of the mitochondrial pyruvate carrier suppresses differentiation in temozolomide and radiation-treated glioblastomaEmma Martell, Helgi Kuzmychova, Harshal Senthil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2023
Intratumoral Delivery of Chimeric Antigen Receptor T Cells Targeting CD133 Effectively Treats Brain MetastasesAgata M Kieliszek, Daniel Mobilio, Deepak Upreti, et al.
Stem Cell Research|January 24, 2012
Bmi1 marks intermediate precursors during differentiation of human brain tumor initiating cellsChitra Venugopal, Na Li, Xin Wang, et al.
Acta Neuropathologica Communications|November 30, 2016
The identification of human pituitary adenoma-initiating cellsBranavan Manoranjan, Sujeivan Mahendram, Saleh A Almenawer, et al.
Journal of Neuro-Oncology|June 24, 2023
An effective kinase inhibition strategy for metastatic recurrent childhood medulloblastomaAshley A Adile, David Bakhshinyan, Yujin Suk, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Oncogene|November 8, 2019
A CD133-AKT-Wnt signaling axis drives glioblastoma brain tumor-initiating cellsBranavan Manoranjan, Chirayu Chokshi, Chitra Venugopal, et al.
Scientific Reports|October 16, 2025
CRISPR screen reveals SOX2 as a critical regulator of CD133 and cellular stress response in glioblastomaNeil Savage, Etienne Danis, Chirayu R Chokshi, et al.
Iscience|April 9, 2025
DAP12-associated synthetic antigen receptors enable multi-targeting of T cells with independent chimeric receptors in a small genetic payloadAllyson E Moore, Hayley Nault, Derek Cummings, et al.
Frontiers in Immunology|July 25, 2022
Dual Antigen T Cell Engagers Targeting CA9 as an Effective Immunotherapeutic Modality for Targeting CA9 in Solid TumorsNazanin Tatari, Xiaoyu Zhang, Shawn C Chafe, et al.
Journal of Alzheimer'S Disease : JAD|April 14, 2009
Challenges associated with metal chelation therapy in Alzheimer's diseaseMuralidhar L Hegde, P Bharathi, Anitha Suram, et al.
Neuro-Oncology|January 11, 2025
Disease stage-specific role of the mitochondrial pyruvate carrier suppresses differentiation in temozolomide and radiation-treated glioblastomaEmma Martell, Helgi Kuzmychova, Harshal Senthil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2023
Intratumoral Delivery of Chimeric Antigen Receptor T Cells Targeting CD133 Effectively Treats Brain MetastasesAgata M Kieliszek, Daniel Mobilio, Deepak Upreti, et al.
Stem Cell Research|January 24, 2012
Bmi1 marks intermediate precursors during differentiation of human brain tumor initiating cellsChitra Venugopal, Na Li, Xin Wang, et al.
Acta Neuropathologica Communications|November 30, 2016
The identification of human pituitary adenoma-initiating cellsBranavan Manoranjan, Sujeivan Mahendram, Saleh A Almenawer, et al.
Journal of Neuro-Oncology|June 24, 2023
An effective kinase inhibition strategy for metastatic recurrent childhood medulloblastomaAshley A Adile, David Bakhshinyan, Yujin Suk, et al.
Pageof 12